Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Non-Current Debt (2022 - 2023)

Historic Non-Current Debt for 60 Degrees Pharmaceuticals (SXTP) over the last 2 years, with Q2 2023 value amounting to $1.2 million.

  • 60 Degrees Pharmaceuticals' Non-Current Debt changed N/A to $1.2 million in Q2 2023 from the same period last year, while for Jun 2023 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Non-Current Debt of $1.2 million as of Q2 2023.
  • 60 Degrees Pharmaceuticals' 5-year Non-Current Debt high stood at $1.2 million for Q2 2023, and its period low was $1.1 million during Q4 2022.